Chitosan-based nano-formulation of berberine isolated from Berberis lycium enhances sustained anticancer effects in MCF-7 cells
Abstract Background Breast cancer remains a major health challenge with limited targeted therapies. Berberine (BBR), an alkaloid from Berberis lycium, has promising pharmacological effects but suffers from poor solubility and bioavailability. This study encapsulates BBR in chitosan nanoparticles to...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
SpringerOpen
2026-05-01
|
| Rangatū: | Future Journal of Pharmaceutical Sciences |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s43094-026-00986-9 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|